Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
15.4%
operating margin TTM
17.28%
revenue TTM
571.63 Thousand
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | 3.07 |
| peg ratio | 0.00 |
| price to book ratio | -1.96 |
| price to sales ratio | 0.25 |
| enterprise value multiple | -0.48 |
| price fair value | -1.96 |
profitability ratios | |
|---|---|
| gross profit margin | 81.63% |
| operating profit margin | 17.28% |
| pretax profit margin | 15.41% |
| net profit margin | 15.4% |
| return on assets | 77.57% |
| return on equity | -41.78% |
| return on capital employed | 216.75% |
liquidity ratios | |
|---|---|
| current ratio | 1.02 |
| quick ratio | 1.02 |
| cash ratio | 0.32 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 4.60 |
| days of payables outstanding | 4.16 |
| cash conversion cycle | 0.44 |
| receivables turnover | 79.42 |
| payables turnover | 87.75 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.94 |
| debt equity ratio | -1.60 |
| long term debt to capitalization | -6.86 |
| total debt to capitalization | 2.67 |
| interest coverage | 6.70 |
| cash flow to debt ratio | -1.19 |
cash flow ratios | |
|---|---|
| free cash flow per share | -5.15 |
| cash per share | 1.01 |
| operating cash flow per share | -5.14 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.19 |
| short term coverage ratios | -6.00 |
| capital expenditure coverage ratio | -774.60 |
Frequently Asked Questions
When was the last time Atara Biotherapeutics, Inc. (NASDAQ:ATRA) reported earnings?
Atara Biotherapeutics, Inc. (ATRA) published its most recent earnings results on 12-11-2025.
What is Atara Biotherapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Atara Biotherapeutics, Inc. (NASDAQ:ATRA)'s trailing twelve months ROE is -41.78%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Atara Biotherapeutics, Inc. (ATRA) currently has a ROA of 77.57%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ATRA's net profit margin stand at?
ATRA reported a profit margin of 15.4% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ATRA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.02 in the most recent quarter. The quick ratio stood at 1.02, with a Debt/Eq ratio of -1.60.